Narasimhan S has been appointed as Senior General Manager – Sales and Marketing at Apollo Proton Cancer Centre, Chennai. With this elevation, he takes on a more strategic leadership role within one of India’s most advanced cancer care facilities, further strengthening its brand positioning and market outreach. His new mandate includes leading marketing initiatives, expanding institutional partnerships, and driving patient engagement strategies to support the centre’s mission of providing cutting-edge oncology care.
Bringing over 15 years of rich experience in healthcare sales, marketing, and business development, Narasimhan’s appointment underscores Apollo’s focus on excellence in leadership and market growth. Prior to this elevation, he served as General Manager – Sales and Marketing at Apollo Proton Cancer Centre for nearly four years, where he played a pivotal role in expanding the hospital’s presence across key markets and enhancing its referral network among oncology specialists.
Before joining Apollo Proton Cancer Centre, Narasimhan worked with the B. Braun Group as Zonal Sales Manager, where he was instrumental in managing regional operations, driving sales strategies, and strengthening customer relationships across multiple healthcare verticals. His tenure there honed his expertise in medical technology marketing, institutional sales, and strategic account management, setting a strong foundation for his current leadership role.
Known for his results-driven approach, cross-functional collaboration, and ability to align sales strategies with patient-centric goals, Narasimhan has earned recognition for building high-performing teams and fostering sustainable business growth. His leadership continues to play a crucial role in positioning Apollo Proton Cancer Centre as a preferred destination for advanced cancer treatment in India and beyond.
In his new role as Senior General Manager – Sales and Marketing, Narasimhan aims to accelerate the hospital’s strategic initiatives, deepen market engagement, and strengthen Apollo’s commitment to pioneering excellence in proton therapy and comprehensive oncology care.